Abstract. 'Rare sugars' are defined as monosaccharides that exist in nature but are only present in limited quantities. The development of mass production method of rare sugars revealed some interesting physiological effects of these on animal cells, but the mechanisms have not been well studied. We examined the effect of D-allose on the proliferation of cancer cells and the underlying molecular mechanism of the action. The HuH-7 hepatocellular carcinoma cells were treated with various monosaccharides for 48 h and D-allose was shown to inhibit cell growth by 40% in a dose-dependent manner. D-allose induced G1 cell cycle arrest but not apoptosis. The microarray analysis revealed that D-allose significantly up-regulated thioredoxin interacting protein (TXNIP) gene expression, which is often suppressed in tumor cells and Western blot analysis confirmed its increase at protein level. The overexpression of TXNIP also induced G1 cell cycle arrest. Analysis of cell cycle regulatory genes showed p27 kip1 , a key regulator of G1/S cell cycle transition, to be increased at the protein but not the transcriptional level. Protein interaction between TXNIP and jab1, and p27 kip1 and jab1, was observed, suggesting stabilization of p27 kip1 protein by the competitive inhibition of jab1-mediated nuclear export of p27 kip1 by TXNIP. In addition, increased interaction and nuclear localization of TXNIP and p27 kip1 were apparent after D-allose treatment. Our findings surprisingly suggest that D-allose, a simple monosaccharide, may act as a novel anticancer agent via unique TXNIP induction and p27 kip1 protein stabilization.
, facilitating studies of the effects of these rare sugars in animals (1). Among the rare sugars, D-psicose and D-allose showed strong scavenging activity toward reactive oxygen species compared with D-glucose and D-fructose, and D-allose inhibited the production of reactive oxygen from neutrophils (2) . D-allose also improved the microcirculation on hepatic ischemia reperfusion (3). Sui et al reported that D-allose inhibited the proliferation of some cancer cell lines (4, 5) , but the underlying mechanisms have remained completely unknown. In this study, we showed that D-allose inhibited cancer cell growth specifically without affecting normal cells and revealed the detail of its molecular mechanism of action via the TXNIP induction. Cell culture. Human hepatocellular carcinoma (HuH-7) cell line was purchased from the Japanese Cancer Research Resources Bank and maintained at 37˚C under a humidified atmosphere of 5% CO 2 in DMEM (Sigma) supplemented with 10% (v/v) fetal bovine serum and 1% penicillinstreptomycin (GE Healthcare). Normal rat hepatocytes were purchased from the Cell Applications Inc. (San Diego, CA). Cells were maintained on the collagen coated dish in the rat hepatocyte maintenance medium (provided with the kit).
Materials and methods

Materials
Construction of expression vector and transfection.
The full-length human TXNIP, p27 kip1 and jab1 cDNA were amplified from normal human liver total RNA (Clontech) using specific primers. The TXNIP cDNA was subcloned into pAcGFP1-N1 (Clontech) or pME18s-FLAG mammalian expression vector (6) . The human p27 kip1 cDNA was subcloned into pCMV-Myc mammalian expression vector (Clontech) and jab1 cDNA was subcloned into pEF4/V5-His mammalian expression vector (Invitrogen), and confirmed by sequencing. Constructs were transfected into the HuH-7 cells with Fugene-6 transfection reagent (Roche) following the manufacturer's protocol.
Cell growth assay. HuH-7 cells were grown in 96-well plates at 7,500 cells/well in 0.1 ml medium and cultured for 24 h. Sugars were added to the medium and the cells were further cultured up to 96 h. Proliferation was measured using the 3-(4,5-dimethyl-thiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) method and relative cell growth was expressed as a percentage of the value for untreated control cultures. For the normal rat hepatocytes assay, 96-well plates were coated with a rat collagen and 30,000 cells/well were seeded. The cells were cultured for 24 h and various concentrations of D-allose, D-psicose, or D-glucose were added to the medium. The cells were further cultured for 48 h and processed for MTT assay.
Cell cycle analysis. Cells were cultured with D-allose and harvested by trypsinization, washed twice with ice-cold PBS and fixed in 70% ethanol for 2 h at 4˚C. After washing with PBS and incubation in PBS containing 50 μg/ml propidium iodide (Wako) and 200 μg/ml RNAse A (Sigma) for 30 min, flow cytometric analysis was preformed with a FACSEpics XL flow cytometer (Beckman Coulter). To examine the effect of TXNIP overexpression, cells were transfected with the human TXNIP cDNA cloned into the pAcGFP1-N1 expression vector (Clontech) using the Fugene-6 transfection reagent (Roche). Only transfected cells were sorted and processed for analysis. Effects on the cell cycle were determined with reference to changes in the percentage cell distribution in each phase of the cell cycle and analyzed using System II software (Beckman Coulter). As a control, the expression vector without TXNIP cDNA was used.
cDNA microarray analysis. Total RNA was isolated from HuH-7 cells treated with or without 50 mM D-allose for 48 h using RNeasy mini kit (Qiagen). Five microgram of each sample was converted to cRNA and labeled with Cyanine 5-or Cyanine 3-CTP using Agilent low linear amplification kit. Each probe was denatured and hybridized to the Agilent human oligo microarray for 17 h at 65˚C. The array was washed with 6X SSPE, 0.005% N-Lauroylsarcosine for 1 min, then 0.06X SSPE, 0.005% N-Lauroylsarcosine for 1 min at room temperature. The array was immersed into the Agilent Stabilization and Drying Solution for 30 sec and dried. The fluorescent signal was scanned using the Agilent microarray scanner and the intensity of signal was analyzed by the feature extraction software (Agilent). The experiment was replicated using different set of samples and data were analyzed with the NIA array analysis software (7) . The statistical significance was determined using ANOVA with the False Discovery Rate (FDR) method (P<0.05) proposed by Benjamini and Hochberg (8) . Genes were classified using the Database for Annotation, Visualization and Integration Discovery (DAVID 2.1) (9).
Real-time quantitative PCR. The HuH-7 cells were cultured in 24-well plates and 50 mM of various sugars were added to the medium and further incubated. Total RNA was purified and used to synthesize cDNAs with random hexamers. Real-time quantitative PCR was carried out using a Taqman gene expression assay primers and the 7300 real-time PCR system (Applied Biosystems). Each reaction was performed in duplicate. The ß-actin gene was used to normalize across assay and runs and the threshold value (Ct) for each sample was used to determine the expression level of the gene.
Western blotting and immunoprecipitation analysis. After sugar treatment, cells were scraped into a lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.5% Triton-X-100, 0.5% NP40) with protease inhibitors and treated with sonication. Samples were centrifuged for 10 min at 14,000 rpm and the supernatant was collected. For Western blot analysis, proteins were separated in 10% SDS-PAGE gels, transferred to nitrocellulose membranes blocked with 5% (w/v) non-fat dried milk in TTBS and incubated with anti-flag (Sigma), anti-myc and anti-V5 (Invitrogen), anti-TXNIP, anti-p27 kip1 , anti-p21 waf1/cip1 , anti-p53, anti-Cdk2, anti-Cdk4, anti-cyclin D1, and anti-cyclin E (MBL), or anti-ß-actin antibodies (Sigma). Membranes were probed with a horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Amersham), and signals were detected with an enhanced chemiluminescence system (Amersham). For immunoprecipitation analysis, proteins were incubated with anti-FLAG M2 agarose (Sigma), anti-V5 agarose (Invitrogen) or anti-myc agarose (Invitrogen) and incubated for 2 h at 4˚C. Samples were washed with 0.1% Triton X-100 in TBS and subjected to Western blot analysis.
Immunohistochemistry. Cells were cultured on glass slides and transfected with flag-TXNIP and myc-p27 kip1 plasmid. After transfection, these cells were further cultured with or without 50 mM D-allose. They were fixed in 4% paraformaldehyde in PBS for 30 min before treatment with cold acetone/methanol for 2 min and blocking with a blocking buffer (3% BSA, 3% goat serum, and 0.1% TritonX-100 in PBS) for 1 h at room temperature. Samples were then incubated with anti-TXNIP or with anti-p27 kip1 antibodies overnight at 4˚C, then with Alexa Flour 488 or Alexa Flour 594 antibodies (Molecular Probes) for 1 h. Signals were observed under an LSM-GB200 confocal laser scanning microscope (Olympus).
Results
Cell growth assay. The effect of rare sugars on HuH-7 cell growth was assayed by the MTT method. D-glucose, D-fructose and D-psicose did not show any growth inhibitory effects compared with control (no sugar addition), but D-allose significantly suppressed cell growth after 96 h (n=3-4) (Fig. 1B) . This effect was dose-dependent and was observed from 5 mM (n=6-11) (Fig. 1C) . Rat hepatic primary culture cells were also treated with D-glucose, D-psicose or D-allose to examine whether the growth inhibition by D-allose is specific to the cancer cell line. No growth inhibitory or cytotoxic effects were observed in the normal cells up to 100 mM of sugars tested (Fig. 1D) .
Cell cycle analysis. Cells were cultured with or without 50 mM D-allose for 96 h, were harvested and nuclei were stained with propidium iodide. The percentage of cells in each cell cycle phase was analyzed with flow cytometry (Fig. 2A) . Without D-allose treatment, 59.0±1.1% of cells were in G1 phase and D-allose significantly increased this to 63.7±1.1% (p<0.05, n=4 each). The percentage in S phase decreased from 28.1±1.2% without D-allose to 24.6±1.3% (n=4 each) with D-allose treatment. These observations suggested that D-allose inhibits the HuH-7 cell growth by inducing the G1 cell cycle arrest.
Western blot analysis of cell cycle regulatory proteins. The expression of cell cycle regulatory proteins was analyzed by Western blot after 48 and 96 h of D-allose treatment. The level of cyclin D1, cyclin E and Cdk4 was not changed, whereas the expression of Cdk2 increased after 48 and 96 h of D-allose treatment (Fig. 2B) . The expression of p21 waf1/cip1 and p53 also showed no clear alteration. The level of the p27 kip1 protein was increased after 96 h both in the presence and absence of D-allose and the extent of the increase with D-allose was significantly greater than without treatment.
Gene expression analysis. The gene expression profiles of HuH-7 cells with or without D-allose treatment was compared by a microarray technique. Approximately 20,000 human genes were analyzed. The experiment was replicated using different set of samples and the statistical significance was determined using ANOVA with the False Discovery Rate (FDR) method (P<0.05). Genes showing >3-fold changes were listed and these genes were classified using the Database for Annotation, Visualization and Integration Discovery (DAVID 2.1) in Table I . There were 37 upregulated and 11 down-regulated genes observed. Among the up-regulated genes, the expression of the TXNIP was most significantly increased >10-fold). This gene has not been functionally classified, but was reported as a tumor suppressor (10) or metastasis suppressor gene (11) . Regarding the cell cycle regulation, the expression of cyclin-dependent kinase inhibitor 2B (CDKN2B) was increased, whereas FK506 binding protein 12-rapamycin associated protein 1 (FRAP1) was decreased. For the transcriptional regulation, homeobox B8 (HOXB8), paired box protein (PAX2) and Tcell acute lymphocytic leukemia 1 (TAL1) was up-regulated and glial cells missing homolog 1 (GCM1) and cofactor Table I . Gene expression profile of HuH-7 cells after D-allose treatment. Table I . Continued. 
-----------------------------------------------------------------------------------------------------Accession no. Gene name Fold change -----------------------------------------------------------------------------------------------------
.69 -----------------------------------------------------------------------------------------------------
Values are ratios of gene expression levels from D-allose treated cells over control. Microarray experiments were replicated using different sets of samples and the statisticals significance of data was analysed using Anova with the Benjamin and Hochberg False Discovery Rate (FDR) method (P<0.05). Genes up-or down-regulated more than 3-fold were listed and classified using the Database for Annotation, Visualization and Integration Discovery (DAVID 21.1). Genes classified in an ontology group containing a few genes are not listed. required for Sp1 transcriptional activation, subunit 3, 130 kDa (CRSP3), transcript variant 1 were down-regulated. D-allose treatment also regulated other genes (5 genes in transporter activity, 9 genes in signal transducer activity, 6 genes in ion binding, 3 genes in nucleotide binding, 5 genes in catalytic activity and 2 genes in structural molecule activity). Eight genes were not classified.
-----------------------------------------------------------------------------------------------------
Real-time PCR and Western blot analysis of TXNIP.
Based on the result of the microarray analysis, we evaluated the expression of TXNIP by real-time PCR. Various sugars were applied to the HuH-7 cells and cells were incubated for 48 h and the levels of TXNIP induction was compared (Fig. 3A) . The D-allose treatment markedly elevated TXNIP expression about 30-fold, although some other sugars including D-mannose, D-gulose and D-glucose also showed a several-fold induction (n=4). The induction of TXNIP by D-allose was already observed after 6 h (n=3-6) (Fig. 3B) . Protein levels of TXNIP were also studied by Western blot (Fig. 3C) . The expression of TXNIP was compared after sugar treatment. TXNIP protein level was significantly increased by D-allose and to a lesser extent by D-glucose treatment (Fig. 3C) . The time course of TXNIP protein level after D-allose treatment revealed that the increase of protein was observed after 6 h and kept at high level until 96 h.
Effect of TXNIP overexpression on cell cycle.
The effect of TXNIP overexpression in HuH-7 cells was examined by constructing a GFP-TXNIP fusion protein expression vector and transfection into HuH-7 cells. After transfection of GFP-TXNIP or GFP expression vector (control), cells were harvested and nuclei were stained with propidium iodide. The cells were sorted by the fluorescence of GFP protein to collect the transfected cells only and the percentage of cells in each cell cycle phase was analyzed (Fig. 3D ). An increase in the percentage of G1 phase cells was observed in the cells expressing GFP-TXNIP protein compared to that of GFP protein [77.7±6.2% and 66.5±4.7%, respectively (p<0.05, n=5 each)].
Immunoprecipitation analysis. To study the molecular mechanism of cell cycle regulation by TXNIP induced by D-allose, the interaction of TXNIP and other interacting proteins, p27 kip1 and jab1, was evaluated. The flag-TXNIP, myc-p27 kip1 and V5-jab1 plasmid were co-transfected into HuH-7 cells and immunoprecipitation and Western blot analysis were performed. Interactions between TXNIP and jab1, and between p27 kip1 and jab1 were observed (Fig. 4A ). In addition, D-allose enhanced the interaction of TXNIP and p27 kip1 , although absolute amounts of the proteins were not significantly altered (Fig. 4B) . Immunohistochemical analysis. The localization of TXNIP and p27 kip1 protein was examined by immunohistochemical study. Cells were cultured on glass slides and transfected with TXNIP and p27 kip1 plasmid before treatment with or without 50 mM D-allose. The localization of these proteins was visualized with anti-TXNIP or with anti-p27 kip1 antibodies followed by fluorescent antibodies. The result demonstrated that overexpressed TXNIP protein was localized mainly in the cytoplasm without D-allose treatment, while p27 kip1 was apparent in both the cytoplasm and nucleus (Fig. 4C) . However, both proteins were predominantly located in the nucleus after D-allose exposure.
Discussion
The HuH-7 cell growth inhibition was observed by D-allose from 5 mM and is specific to the cancer cells as there was no growth inhibitory or cytotoxic effect on the normal liver cells (Fig. 1D) . D-allose inhibited the cell growth by inducing the cell cycle arrest. Compared with the control, D-allose increased the percentage of cells in G1 phase (Fig. 2A) . The Western blot analysis showed significant increase of p27 kip1 protein by D-allose compared to control (Fig. 2B) . Cell cycle progression is tightly regulated by regulatory proteins including cyclins, cyclin-dependent kinases (Cdks) and Cdk inhibitors (12, 13) . Since p27 kip1 is a key regulator of the To analyze the molecular mechanism in detail, we performed gene expression analysis by the microarray technique. Genes showing >3-fold change are listed in Table I . There were 37 up-regulated and 11 down-regulated genes. Among these, the TXNIP expression was most significantly up-regulated (10.5-fold). This gene was originally cloned as a vitamin D3 up-regulated protein (VDUP1) after 1,25-dihydroxyvitamin D3 treatment of HL-60 cells (15) . TXNIP is known to interact with thioredoxin and is involved in the regulation of the redox state of cells (16) . This gene is also known as a tumor suppressor (10) or metastasis suppressor (11) , and its expression is lower in cancer, including colorectal, gastric and breast cancers, than in normal cells (17, 18) . This might explain why D-allose inhibits growth of cancer cells effectively without affecting normal cells via TXNIP induction (Fig. 1B and D) . In addition, TXNIPdeficient mice show an increased incidence of hepatocellular carcinoma (19) , indicating that TXNIP expression is important for the suppression of abnormal cell proliferation such as cancers. In this study, the overexpression of TXNIP caused G1 cell cycle arrest in HuH-7 cells (Fig. 3D) . This result supported the idea that the up-regulated TXNIP by D-allose is a key factor for growth inhibition. We compared the TXNIP induction by different sugars and it was more significant by D-allose than other sugars tested (Fig. 3A) . The increase of TXNIP was observed after 6 h of D-allose treatment ( Fig. 3B and C (20, 21) . As the structures of D-glucose and D-allose are similar (Fig. 1A) , induction by D-allose might be via the similar mechanism, but further investigations are necessary. The microarray analysis showed up-regulation of CDKN2B and downregulation of FRAP1 (Table I) . CDKN2B is one of the CDK inhibitors and controls the G1 cell cycle progression. The FRAP1 has serine/threonine kinase activity and promotes G1 phase progression through signaling to p70/S6 kinase and 4EBP1 (properties of heat and acid stability/eukaryotic initiation factor 4E-binding protein) (22) . The increase of CDKN2B and decrease of FRAP1 expression may also contribute the growth inhibitory effect of D-allose.
Regarding the cell cycle regulatory protein, the increase of the p27 kip1 protein by D-allose was observed without any transcriptional induction (data not shown), indicating possible enhancement of protein stability. Nuclear p27 kip1 is generally exported to the cytoplasm for ubiquitination and degraded by the 26S proteosome (23) . Interestingly, increased rates of proteosome mediated degradation suppress protein levels of p27 kip1 in cancer cells (24) . Nuclear export of p27 kip1 is known to be mediated by the jab1 (25) , originally identified as a co-activator of c-jun and junD (26) , incorporated into the COP9 signalosome involved in modulation of gene transcription, signal transduction and protein stability (23) . TXNIP is reported to interact with the jab1 competitively and inhibit p27 kip1 transport, resulting in increased protein levels (27) . The immunoprecipitation study confirmed the interaction between TXNIP and jab1, and between p27 kip1 and jab1 (Fig. 4A) . These findings support the work of other research groups (25, 27) . In addition, we report the first observation of the direct interaction between TXNIP and p27 kip1 which was significantly enhanced after D-allose treatment (Fig. 4B) . The immunohistochemical study showed that overexpressed TXNIP protein was localized mainly in the cytoplasm without D-allose, while p27 kip1 was apparent in both the cytoplasm and nucleus (Fig. 4C) . In contrast, both proteins were predominantly located in the nucleus after D-allose exposure. Together with the immunoprecipitation results, it was suggested that D-allose may cause p27 kip1 stabilization by restricting the protein to nuclei, possibly through competitive inhibition of the binding of p27 kip1 and jab1 by TXNIP. In addition, transfer of TXNIP to nuclei would clearly facilitate direct interaction with p27 kip1 and contribute to its stabilization.
In conclusion, our study generated strong evidence that D-allose may inhibit the growth of cancer cells by specific TXNIP induction and subsequent p27 kip1 protein stabilization, without exerting appreciable effects on normal cells. D-allose may thus be useful as a novel anticancer drug, providing a new strategy for therapy or prevention in pre-cancerous patients.
